Professional Summary

Professional Overview

Kevin Richardson is an experienced pharmaceutical executive with a proven track record of driving growth and operational excellence. As the CEO Americas for Telix Pharmaceuticals Limited, he leverages his deep industry expertise to lead the company's strategic and commercial initiatives across the Americas region.

Experience Summary

Current Role

As the CEO Americas at Telix Pharmaceuticals Limited, Kevin is responsible for overseeing the company's business operations and driving the strategic expansion of its innovative radiopharmaceutical solutions in the Americas. He is focused on strengthening Telix's presence, enhancing commercial capabilities, and delivering positive patient outcomes.

Career Progression

Prior to his current role, Kevin held various leadership positions within the medical device and pharmaceutical industries. He served as the President and Chief Operating Officer at UroShape Medical, LLC, where he led the company's operational and commercial strategies. Earlier, he was the CEO Americas and US Vice President/General Manager at Sirtex Medical Limited, where he spearheaded the company's growth and market penetration in the region.

Kevin's extensive experience also includes roles at St. Jude Medical and Boston Scientific, where he held senior marketing and sales leadership positions, contributing to the success of their cardiovascular and medical device portfolios.

Academic Background

Kevin holds an MBA in International Finance from The University of Texas at Arlington and a Bachelor of Business Administration in Banking, Corporate Finance, and Securities Law, also from The University of Texas at Arlington.

Areas of Expertise

• Pharmaceutical and medical device industry expertise

• Strategic leadership and business acumen

• Commercial operations and market expansion

• Financial management and business development

• Cross-functional team building and collaboration

Professional Impact

Throughout his career, Kevin has demonstrated his ability to drive organizational growth, improve operational efficiency, and deliver innovative solutions that positively impact patient care. He is recognized for his strategic vision, collaborative leadership, and relentless focus on delivering measurable results.

Conclusion

With his extensive experience, industry expertise, and proven leadership skills, Kevin Richardson is well-positioned to guide Telix Pharmaceuticals Limited's continued success and expansion in the Americas. His unwavering commitment to enhancing patient outcomes and driving innovative solutions makes him a valuable asset to the company and the broader pharmaceutical industry.